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INTRODUCTION 
 
Sundowning describes an array of neuropsychiatric 
symptoms and is a common occurrence among 
individuals with dementia. The highest prevalence 
occurs in community-dwelling and institutionalized 
older adults (Canevelli et al., 2016; Gnanasekaran, 
2015). During sundowning, symptoms such as 
confusion, agitation, and aggression typically 
emerge in the late afternoon when light exposure 
is diminished (Canevelli et al., 2016). A higher 
incidence of sundowning has been reported in 
individuals with advanced stages of dementia, as 
well as during the winter months when there is less 
sunlight (Canevelli et al., 2016). It is believed that 
sundowning hastens the progression of cognitive 
impairment and increases the rates of 
hospitalization, institutionalization, and caregiver 
burnout (Canevelli et al., 2016).  
 
Sundowning has been recognized by medical 
professionals for over 70 years; yet, it is not 
included in the Diagnostic and Statistical Manual of 
Mental Disorders (DSM–5) (Gnanasekaran, 2015). 
Presently, there are no established guidelines for 
the management of symptoms associated with 
sundowning syndrome. Although pharmacological 
interventions have been used for treatment of 
sundowning, their effectiveness is limited and the 
risk of interacting with other medications is high 
(Gnanasekaran, 2015).  
 
Non-pharmacological interventions, such as 
environmental modifications, have emerged as 
safer alternatives to medication; however, their 
efficacy is still unknown (Gnanasekaran, 2015). 
One of these emerging alternatives to traditional 
treatment is light therapy (Gnanasekaran, 2015). 
The effects of light therapy on sundowning have 
not been widely studied. Nevertheless, the limited 
research available has suggested its potential to 
improve symptoms (Gnanasekaran, 2015). This 
systematic review seeks to answer the question: is 
light therapy an effective intervention for 
sundowning symptoms experienced by individuals 
who have dementia? 
 
 
 
METHODS 
A protocol was developed prior to conducting a 
comprehensive systematic review (Appendix A). 
The protocol is a step-by-step procedure to identify 
and appraise all relevant studies.  
Identification of Relevant Studies: 
A comprehensive and systematic search for 
relevant studies was conducted in February and 
March of 2019, using the following databases: 
PsychINFO, OT Search, OT Seeker, CINAHL, 
TEXT BOX 1 
 
Dementia: Overarching term that describes 
a group of symptoms related to cognitive 
impairment, a decline in memory, and 
decreased functioning. 
 
Sundowning: Overarching term for 
neuropsychiatric symptoms (e.g. agitation, 
aggression, and confusion) that emerges in 
individuals with dementia due to lack of 
exposure to light (Canevelli et al., 2016).  
 
Pharmacological: Medications and drugs 
used to treat illness. 
 
Non-pharmacological: Alternative therapies 
to medications and drugs. 
 
Light therapy: The treatment of medical or 
psychiatric conditions by the controlled 
application of light. 
 
 
 
 
 
 
 
Health & Medical Complete, Cochrane, and 
PubMed. The inclusion and exclusion criteria 
included: (1) quantitative study (2) published in 
English and (3) peer-reviewed. The search terms 
used, keyword combinations, and subject headings 
relative to each database can be found in the 
protocol (Table 3).   
 
To be included in the systematic review, studies 
retrieved during the search met the following 
criteria: (1) population with a diagnosis  of 
dementia, (2) light therapy used as the primary 
means of intervention, (3) the outcome measured 
at least one of three predetermined characteristics 
of sundowning (agitation, confusion, and 
aggression). Studies whose population had 
comorbid conditions causing memory loss (e.g. 
traumatic brain injuries or seizures) were excluded. 
Also excluded were articles that discussed other 
forms of light therapy not as defined in Text Box 1 
(e.g. color therapy, heliotherapy, wave therapy, 
etc.). A complete list of inclusion and exclusion 
criteria was established in the protocol (Table 5).  
 
A group of six reviewers and six research 
assistants independently assessed articles 
retrieved from the selected databases using the 
predetermined inclusion and exclusion criteria. The 
title and abstract of each study were screened by 
two reviewers to determine article eligibility. When 
a determination from these sections alone could 
not be reached, the full article was assessed. 
Following independent assessment, the two 
assigned reviewers compared their findings of 
each article and discussed and resolved any 
discrepancies until a consensus was reached. 
When necessary, a third reviewer was utilized to 
assist with resolving discrepancies between the 
two assigned reviewers. All the articles included or 
excluded were summarized in a flowchart (Figure 
1). 
 
Appraisal of Included Studies: 
After all inclusion and exclusion criteria were 
applied and the authors came to a consensus 
there were 16 articles (Figure 1). In compliance 
with the protocol, two independent reviewers 
appraised each article to determine the quality of 
evidence (Text Box 2) by using predetermined, 
study design-specific criteria. Each pair of 
reviewers compared individual ratings of the quality 
of evidence for each study (Table 6). 
Discrepancies between reviewers were resolved 
through discussion until a consensus was reached. 
A third party reviewer was consulted when an 
agreement could not be agreed upon.  
Collaboratively, the two reviewers compiled 
recorded findings into a descriptive table detailing 
nine categories: design type, quality of evidence, 
study population, intervention and sample size, 
outcomes, measurement tools, point estimate, 
clinical significance, and statistical significance 
(Table 7). Relevant statistical terminology is 
defined in Text Box 2. In cases with no reported 
clinical significance, a manual calculation of the 
minimally detectable difference (MDD) was 
performed when possible. Practice 
recommendations and clinical implications were 
generated from findings.  
  
RESULTS 
 
The database searches retrieved a total of 701 
articles. There were 16 articles that met pre-
established inclusion criteria and were 
subsequently reviewed. The flowchart provides a 
detailed breakdown of the study identification 
process (Figure 1).  
TEXT BOX 2:  
Statistical Significance: A term indicating 
that the results of a study are unlikely to be 
the result of chance. (Portney & Watkins, 
2009) 
 
Level of Evidence: A ranking system used to 
show the strength of a study based on 
predetermined criteria. 
 
Quality of Evidence: the degree to which 
the study being analyzed is deemed reliable.  
 
Point Estimate: numerical data presented as 
mean scores with standard deviations. 
 
Minimally Detectable Differences (MDD): 
the smallest amount of change that can be 
detected to reflect the true difference. 
(Portney & Watkins, 2009) 
 
Minimally Clinically Important Difference 
(MCID): the smallest difference  detected that 
the patient perceives to be beneficial. 
(Portney & Watkins, 2009) 
 
Effect Size: An expression that represents 
magnitude of the difference between two 
treatments or the magnitude of a relationship 
between to variables. (Portn y & W tkins, 
2009) 
 
Clinical significance: Whether the change 
observed in a study is large enough to make 
a difference in the patient’s quality of life or is 
detectable by the patient. 
 
 
 
 
Of the analyzed studies, seven of the studies 
followed a quasi-experimental study design, 
involving the application of the intervention without 
random assignment of participants to conditions or 
orders of conditions. Two studies were single case 
research designs, where participants serve as their 
own control while also receiving the intervention. In 
this case, repeated measures are recorded at 
multiple phases: baseline, intervention, and follow-
up or withdrawal. Seven studies were randomized 
control trials (RCTs), in which group allocation 
(control or intervention) was determined through a 
process of randomization. RCTs are considered 
level I evidence, one of the highest levels of 
evidence in intervention studies.  
 
The level of evidence of the studies analyzed in 
this systematic review ranged from level I to IV with 
levels I and III being the most frequently 
represented. The quality of individual studies 
ranged from low to high and can be found on the 
quality of evidence table (Table 6). A total of 11 
studies ranged from moderate to high-quality 
evidence, while five were found to be of low quality 
(Table 6). Four studies presented with high quality, 
meeting 70% or more of design specific criteria 
and seven studies presented with moderate quality 
ranging from 40% to 70% of criteria being met. 
Five articles were low quality, meeting less than 
40% of design specific criteria (Table 6). The 
included studies measured at least one of three 
identified outcomes related to sundowning: (1) 
agitation, (2) aggression or (3) confusion.  
 
Agitation 
Of the 16 included studies, 15 evaluated the 
efficacy of light therapy when utilized as an 
intervention to treat agitation. In regards to level of 
evidence, five of these studies provided level I 
evidence, four provided level III, and four provided 
level IV (Table 6). The quality of evidence ranged 
from low to high. Four studies presented with low 
quality, six with moderate quality, and three with 
high quality (Table 6). 
 
There were 10 outcome measures utilized to 
evaluate agitation across the 15 identified studies; 
with some studies utilizing more than one outcome 
measure to estimate agitation (Table 8). There 
were 10 studies that utilized six of the identified 
outcome measures and found light therapy to be 
effective in treating agitation (p<0.05; Table 8). 
Three studies, through three outcome measures, 
found no statistical significance and two studies 
which utilized the outcome measures of 
observation and the Confusion Rating Scale (CRS) 
did not provide information regarding statistical 
significance (Table 8).  
 
In regards to clinical significance, 11 studies using 
eight outcome measures found no clinical 
significance when utilizing light therapy as an 
intervention to decrease agitation (Table 8). Two 
studies, which both utilized the Cohen-Mansfield 
Agitation Inventory (CMAI) as an outcome 
measure, found light therapy to be a clinically 
significant intervention and two studies did not 
provide information regarding clinical significance 
nor provide sufficient data for significance to be 
calculated by reviewers (Table 8).  
 
Aggression 
Five of the studies included in the systematic 
review evaluated the efficacy of light therapy for 
treating aggression. Two of these studies provided 
level I evidence, with one being high-quality 
evidence and one being low-quality evidence 
(Table 8). The remaining three studies provided 
low-quality, level III evidence (Table 8). There were 
six outcome measures utilized across the five 
identified studies which measured agitation (Table 
8). Three studies, using four of the identified 
outcome measures among them, found light 
therapy to be effective in decreasing aggression 
(p<0.05; Table 8). One study, which utilized both 
the Gedragsobservatieschaal voor Intramurale 
Psychogeriatrie (GIP) and the Social Dysfunction 
and Aggression Scale (SDAS-9) as outcome 
measures for aggression, found mixed results in 
regard to statistical significance and one study did 
not provide information regarding statistical 
significance (Table 8).   
 
In determining the clinical significance of utilizing 
light therapy as an intervention to decrease 
aggression, one study that utilized the Behavioral 
Pathology in Alzheimer Disease Scale (BEHAVE-
 
 
 
AD) as an outcome measure found clinical 
significance. Two studies found no clinical 
significance and one study did not provide 
information regarding clinical significance nor 
sufficient data for significance to be calculated by 
reviewers (Table 8). The remaining study which 
utilized both the GIP and SDAS-9 to estimate 
aggression found no clinical significance among 
the results of the GIP, and did not provide 
information regarding clinical significance from the 
results of the SDAS-9 (Table 8).  
 
Confusion 
Five out of the 16 included studies evaluated the 
efficacy of light therapy as an intervention to treat 
the sundowning symptoms of confusion. Three of 
these studies provided level I evidence, and two 
studies provided level IV evidence (Table 8). The 
quality of evidence among the five identified 
studies ranged from low to high. Two studies had 
high quality evidence, two studies had moderate 
quality evidence, and one study had low-quality 
evidence (Table 8).  
 
Within the five relevant studies, there were five 
outcome measures utilized to evaluate confusion 
(Table 8). One study which utilized the GIP as an 
outcome measure, found light therapy to be 
effective in decreasing confusion (p<0.05; Table 
8). Three studies found no statistical significance, 
and one study, which utilized the CRS to estimate 
confusion did not provide information regarding 
statistical significance (Table 8). In regards to 
clinical significance, two studies found light therapy 
to have clinically significant results in treating 
symptoms of confusion, while three studies did not 
(Table 8).  
PRACTICE RECOMMENDATIONS 
Agitation 
There were 15 studies that met this systematic 
review inclusion criteria addressed the 
effectiveness of light therapy in the treatment of 
agitation. The level of evidence ranged from Level 
I to level III, with a preponderance of level I 
studies. Using a modified Grading of 
Recommendations Assessment, Development and 
Evaluation (GRADE) system, this outcome 
demonstrated low quality due to many of the 
studies yielding mixed results regarding clinical 
and statistical significance. As well as the 
individual studies having low quality of evidence 
regardless of level of evidence. Further research 
will most likely impact the reviewers’ confidence in 
the estimate of effect and more organized and 
structured study designs with larger study 
populations are suggested for more evidence. 
(Guyatt et al, 2011).  
 
Aggression 
Five studies analyzed in this systematic review 
addressed the use of light therapy in reducing 
sundowning symptoms, specifically aggression. 
The level of evidence ranged from level I to level III 
with a preponderance of level III studies. Using a 
modified GRADES classification system, this 
outcome demonstrated low quality because only 
one of the six studies resulted in high quality of 
evidence (Guyatt et al, 2011). This indicates that 
further research will most likely impact confidence 
in the estimate of effect. Higher level studies with 
better quality levels are suggested in order to 
increase the validity and reliability of research 
evidence (Guyatt et al, 2011).  
 
Confusion 
Five of the 16 studies analyzed in this systematic 
review addressed the use of light therapy in 
reducing the sundowning symptoms related to 
confusion. A preponderance of these studies were 
RCTs, which are considered level I evidence. 
However, due to discrepancies in both the levels of 
quality of evidence and the clinical and statistical 
significance results, this outcome is considered of 
moderate quality based on the GRADES 
classification system (Guyatt et al, 2011). Further 
research is likely to have an impact on confidence 
in the estimate of effect. Rigorous study methods 
and designs are suggested for future studies with 
the expectation that improved research validity is 
produced. 
 
CLINICAL IMPLICATIONS 
The 16 included studies in this systematic review 
evaluated the efficacy of light therapy on 
sundowning symptoms in individuals with 
dementia. The three outcomes addressed— 
agitation, aggression, and confusion—were 
considered to have low and moderate quality 
based on the GRADES classification system  
(Guyatt et al, 2011).  
 
 
 
 
Confusion was considered to have a moderate 
quality designation from the modified GRADES 
system which suggests that further research is 
necessary and may impact clinical understanding 
of light therapy and its effect on sundowning 
symptoms in the future. However, agitation and 
aggression were both found to have low-quality 
based on the GRADES classification system, 
which suggests that further research is necessary 
and will impact clinical understanding of light 
therapy and its effect on sundowning symptoms in 
the future. 
  
This systematic review shows that currently, the 
preponderance of evidence provided in these 
studies had moderate to low clinical significance 
and p-values that demonstrated low statistical 
significance. The benefits of utilizing light therapy 
as an intervention to reduce sundowning 
symptoms are unclear. Clinicians must analyze 
each case, taking into consideration the cost and 
burden of specialized lighting equipment, as well 
as the lengthy administration time and supervision 
needed for the intervention. Although study 
limitations exist, utilizing bright light therapy to treat 
sundowning symptoms is an option that would be 
weakly recommended when addressing 
aggression, agitation, and confusion in individuals 
with dementia. This is due to the low to moderate 
clinical significance of the three outcomes 
analyzed. The significance of the outcomes were 
further limited by multiple lower level studies and 
limited sample sizes. Therefore, it is suggested 
that clinicians discuss the potential risks and 
benefits, as well as the unknown effectiveness, 
with clients and their families before implementing 
this intervention. 
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Table 1 
PICO question 
P - 
Individuals with 
dementia 
  
I - 
Light therapy 
C - 
* no comparison 
needed 
O – 
Decreased 
sundowning 
behaviors 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Table 2. List of the Databases to be Searched: 
Databases Included in SR 
Search 
Planned the Search 
  
Will conduct the Search 
Person 1 Person 2 Person 1 Person 2 
 PubMed  group group Amanda  Christine 
 Cinahl  Alyssa  Amanda  Christine Vivian 
 PsychINFO  Christine Erica Elise Amanda 
 OT Seeker  Vivian Erica Alyssa Amanda 
 OT Search  Alyssa Amanda Christine Elise 
 Health and Medical Complete  Vivian Elise Erica Alyssa 
 Cochrane Elise Christine Vivian Erica 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3. List of Search Terms: 
  Construct 1 Construct 2 Limits (if 
any) 
Database Subject 
Headings 
Keywords Subject 
Headings 
Keywords   
Health and 
Medical 
Complete 
(ProQuest 
Thesaurus, 
NOT MeSH) 
 Dementia Dementia (all 
subjects & 
indexing-SU), 
“neurocogniti
ve dis*” (all 
subjects & 
indexing-SU), 
Alzheimer* 
(all subjects 
& indexing-
SU) 
 
A cross 
search was 
run using 
keywords in 
all fields vs 
keywords in 
SU and the 
remaining 
results were 
irrelevant 
 
Light therapy Phototherapy
, light 
therap*, light 
treatment 
 
 
*light 
treatment 
has to be 
utilized as a 
keyword for 
this database 
as it retrieves 
relevant 
results that 
are not 
included 
when 
searched 
without it 
 
 PsycINFO Dementia  Dementia, 
Alzheimer*, 
“Neurocogniti
ve Dis*” 
Phototherapy 
 
 
 
 
 
 
 
Phototherapy
, “Light 
therap*”,  
 
“light 
treatment”- 
not included 
as it did not 
effect 
relevant 
Subject 
headings 
found in apa 
thesaurus 
 
 
 
search 
results 
 CINAHL Dementia 
[MeSH] OR 
“neurocogniti
ve disease 
[MeSH]” 
Dementia OR 
“Neurocogniti
ve dis” 
 
Phototherapy 
[MeSH] 
“Light 
Therap*” OR 
“Phototherap
*” 
  
 OT Seeker **no subject 
headings 
recognized 
“Neurodegen
erative dis*” 
Alzheimer’s 
Dementia 
 
**-
degenerative 
vs. -cognitive. 
-cognitive 
yields 0 
results. 
**no subject 
headings 
recognized 
“Light 
therap*” 
***Tried 
phototherapy
, came up 
with 3 results, 
2 of which 
were same 
as light 
therapy, one 
was 
irrelevant.  
  
OT Search 
 
*This site 
does not 
utilize 
subject 
headings* 
Dementia, 
Alzheimer, 
neurocognitiv
e disease 
*This site 
does not 
utilize 
subject 
headings* 
Phototherapy 
OR light 
therapy 
 
*This site 
does not 
recognize 
truncation* 
 
Cochrane Not 
necessary 
to include 
subject 
heading as 
keyword 
search 
returns only 
4 results (1 
relevant) 
Dementia OR 
“neurocogniti
ve disorder” 
Not 
necessary 
to include 
subject 
heading as 
keyword 
search 
returns only 
4 results (1 
relevant) 
“Light 
therapy” OR 
phototherapy 
 
PubMed Dementia Dementia, 
Neurocognitiv
Phototherapy Phototherapy
, light therap* 
 
 
 
 
 
e disorder, 
Alzheimer* 
Note:  
● Cochrane Library: Use search category  “title, abstract, keywords” 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table 4. Boolean Sentence for each database: 
Database Name Boolean Sentence 
 PsycINFO (IndexTermsFilt: "Phototherapy" OR Any Field: phototherapy OR Any 
Field: ("light therap*"))AND (IndexTermsFilt: "Dementia" OR Any Field: 
dementia OR Any Field: alzheimer* OR Any Field: ("neurocognitive 
dis*")) 
Health and 
Medical 
Complete 
 MAINSUBJECT.EXACT("Dementia") OR su("neurocognitive dis*") 
OR su(dementia) OR su("alzheimer*") AND 
(MAINSUBJECT.EXACT("Light therap*") OR Phototherapy OR 
“Light therapy” OR “Light treatment”) 
 CINAHL  (“Dementia [MeSH]” OR “Dementia*” OR “Neurocognitive disease  
[MeSH]” OR “Neurocognitive dis*”) AND (“Phototherapy [MeSH]” 
OR “Phototherapy*” OR “Light therap**”) 
 OT Seeker (Alzheimer’s OR dementia) AND (“Light therapy”)  ***Tried 
phototherapy, came up with 3 results, 2 of which were same as 
light therapy, one was irrelevant.*** 
 OT Search 
(POWER 
SEARCH)  
 ("Dementia" OR "Alzheimer" OR "neurocognitive disease") AND 
("light therapy" OR "phototherapy") 
Cochrane (Dementia OR “neurocognitive disorder”) AND (“Light therapy” 
OR Phototherapy) 
PubMed (“Dementia” [Mesh] OR Dementia OR “Neurocognitive disorder” 
OR Alzheimer*) AND (“Phototherapy” [Mesh] OR “light therap*” OR 
phototherapy) 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5. Article inclusion and Exclusion Criteria 
Inclusion Criteria 
Population Intervention and 
Comparison 
Outcome Other 
 Dementia Light therapy 
(The treatment of 
medical or psychiatric 
conditions by the 
controlled application 
of light.) 
Sundowning behavior Peer Reviewed 
English 
Quantitative studies 
 Any type of 
dementia 
  Must have at least 1 
of 3 characteristics of 
sundowning 
(agitation, confusion, 
and aggression) 
 
 All races, 
ethnicities, genders, 
socioeconomic 
statuses 
      
Any stage of 
dementia 
      
Exclusion Criteria 
Population Intervention and 
Comparison 
Outcome Other 
Not memory loss 
due to other 
conditions ex. TBI or 
seizures 
Not color therapy     
  Not heliotherapy    
  Not wave therapy     
  Not low-level light 
therapy 
    
 
 
 
(Defined as Low-level 
laser therapy is a 
form of alternative 
medicine that applies 
low-level lasers or 
light-emitting diodes 
to the surface of or in 
orifices of the body) 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6. Quality of Evidence Worksheet 
  
  Quality Criteria     
Citation Type 
of 
design 
1 2 3 4 5 6 7 8 9 10 Quality 
Level 
Evidence 
Level 
Ancoli et al., 
2003 
3 1  0  1  1  0 0  0 0  1  0 Moderate 1 
Barrick, A. L., 
et al., 2010 
6  0  1 1 0 0 1 0 1 n/a n/a  
Moderate  
3  
Burns et al. 
2009 
3 1 0 1 1 1 1 1 1 1 0 High 1 
Dowling, Graf, 
Hubbard, & 
Luxenberg, 
2007 
3 1 0 1 1 0 1 0 1 1 1 High 1 
Figueiro et al., 
2014 
6 0 1 0 0 1 0 0 0 n/a n/a Low 3 
Haffmans et 
al., 2001 
3   
0 
0  0  1  1  0  1  0  1  0  Moderate  1 
Lovell et al., 
1995 
7 1 1 1 1 0 1 1 1 n/a n/a High 4 
Lyketsos et 
al., 1999 
3 0 0 1 1 1 0 0 0 1 0  
Moderate 
1 
Munch et al., 
2017 
5 0 1 1 0 0 0 1 1 0 1 Moderate 2 
Onega, Pierce 
& Epperly, 
2016 
3 0 0 0 1 1 0 1 1 1 0 Moderate 1 
Riemersma et 
al., 2008 
3 1 1 0 1 1 1 1 1 0 0 High 1 
Satlin, et al, 
1992 
6 0 1 0 0 0 0 1 0 n/a n/a Low 3 
 
 
 
Schindler, et 
al, 2002 
7 0 1 0 0 0 0 0 1 n/a n/a Low 4 
Skjerve et al., 
2004 
6 0 1 0 0 1 1 0 0 n/a n/a Low 3 
Thorpe et al., 
2000 
 
6 0  0 0 0 1 1 0 0 n/a n/a Low 3 
Wahnschaffe 
et al., 2017  
7 0 1 1 1 0 0 0 1 n/a n/a Moderate 4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 7. Study Description Table 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8. Results Summary 
 
# of 
Articl
es 
Level of 
Evidenc
e  
Quality of 
Evidence 
Outcome 
Measures 
Statistical 
Significance 
Clinical 
Significance 
Agitation 
15 I - IV 
 
 
Low: 5 
Moderate: 6 
High: 4 
 
1.CMAI (9) 
2.ABRS (2) 
3. CRBRS (1) 
4. NPI-NH (1) 
5. BEHAVE-AD (1) 
6. CADS (1) 
7. CRS (1) 
8. BARS (1) 
9. PAS (1) 
10.Observation (1) 
 
1 S. (6) 
   N.S (3) 
2. S. (2) 
3. N.S (1) 
4. S. (1) 
5. N.S.(1) 
6. S. (1) 
7. Not Provided 
8. S. (1) 
9. S. (1) 
10. Not Provided 
1. S. (3) 
       N.S.(6) 
2. N.S (2) 
3. N.S. (1) 
4. N.S.(1) 
5. N.S. (1) 
6. Not Calculable 
7. N.S (1) 
8. N.S. (1) 
9. N.S. (1) 
10. Not Calculable 
Aggression 
5 I-III Low: 3 
Moderate: 1 
High: 1 
 
  1. NPI-NH (1)  
2.  GIP (1) 
3. SDAS-9 (1) 
4. BEHAVE-AD (1) 
5.  EBIC (1) 
6.. Observation (1) 
1 S. (1) 
2. S. (1) 
3. N.S. (1) 
4. S. (1) 
5. S. (1) 
6.. Not Provided  
1.N.S.(1) 
2. N.S. (1) 
3. Not Calculable 
4. S. (1) 
5. N.S. (1) 
6. Not Calculable  
Confusion 
5 I-IV Low: 1  
Moderate: 2 
High: 2 
 
 
1.GIP (1) 
2. S-MMSE (1) 
3. NPI-Q (1) 
4.CRS (1) 
5. MOUSEPAD (1) 
1.S.(1) 
2. N.S. (1) 
3. N.S. (1) 
4. Not Provided 
5. N.S. (1) 
1.N.S. (1) 
2. S. (1) 
3. S. (1) 
4. N.S. (1) 
5. N.S. 
 
KEY:  
S= SIGNIFICANT 
N.S= NOT SIGNIFICANT 
 
OUTCOME MEASURES: 
ABRS: Agitated Behavior Rating Scale 
BARS: Brief Agitation Rating Scale 
Behave-AD: Behavioral Pathology in Alzheimer Disease scale 
CADS: Change in Advanced Dementia Score  
CMAI: Cohen-Mansfield Agitation Inventory  
CRBRS: Crichton Royal Behavior Rating Scale  
 
 
 
CRS: Confusion Rating Scale 
CS: Clinically Significant 
EBIC: Environment-Behavior Interaction Cod 
GIP: Gedragsobservatieschaal voor Intramurale Psychogeriatrie (Dutch version of the geriatric 
behavioural observation scale) 
MOUSEPAD: Manchester and Oxford Universities Scale for the Psychopathological Assessment of 
Dementia 
NPI-NH: Neuropsychiatric Inventory-Nursing Home  
PAS: Pittsburgh Agitation Scale 
SDAS-9: Social Dysfunction and Aggression Scale 
S-MMSE: Severe Mini Mental Status Evaluation  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Flowchart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Number of studies identified 
through database search = 701 
  
PsychINFO: 108 
OT Search: 4 
OT Seeker: 7 
CINAHL: 102 
Health & Medical Complete: 302 
Cochrane: 4  
Pubmed: 174 
 
 
 
 
 
 
Duplicates Removed: 22 
 
Number of articles included in 
Systematic Review: 17 
 
Number of studies excluded after 
screening “Title and Abstract”= 662 
  
Causes of Exclusion: 
Not peer reviewed: 24 
Not published in English: 2 
Not Quantitative Study: 133 
Systematic Review: 21 
Population not individuals with 
dementia: 69 
Intervention is not “light therapy” 
(as defined by reviewers): 203 
Outcome does not include 
decreasing “sundowning” behavior 
(as defined by reviewers):  211 
 
 
Total Number of Remaining Articles: 39 
 
 
 
1 article unable to be retrieved 
 
Number of articles included in 
Systematic Review: 16 
